Drugs / AMZ002
last change Dec 2025 re-read 2 minutes ago

AMZ002

Developed for
infantile spasms
Investigated by
Amzell

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05128344 Apr 2023 → Jun 2025 infantile spasms Amzell Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AMZ002 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05128344